We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-0.62%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.63B
AUM Growth
+$871M
Cap. Flow
-$403M
Cap. Flow %
-7.15%
Top 10 Hldgs %
32.98%
Holding
166
New
29
Increased
30
Reduced
12
Closed
23

Top Buys

Rank Stock Value
1
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$235M
2
AHCO icon
AdaptHealth
AHCO
+$145M
3
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$132M
4
ORGO icon
Organogenesis Holdings
ORGO
+$78.8M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$50.1M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$110M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$88.6M
3
BIIB icon
Biogen
BIIB
+$86.7M
4
CNC icon
Centene
CNC
+$67.9M
5
TOI icon
The Oncology Institute
TOI
+$55M

Sector Composition

Rank Sector Weight
1 Healthcare 68.23%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMPMU
101
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
$7.54M 0.13%
750,000
– –
IGNYU
102
DELISTED
Ignyte Acquisition Corp. Unit
IGNYU
$7.26M 0.13%
725,000
– –
TPTX
103
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$6.54M 0.12%
83,846
– –
DCTH icon
104
Delcath Systems
DCTH
$422M
$6.3M 0.11%
500,000
– –
TALK icon
105
Talkspace
TALK
$873M
$6.23M 0.11%
+750,000
New +$7.29M
INSM icon
106
Insmed
INSM
$23.2B
$5.69M 0.1%
+200,000
New +$5.94M
CHFW.U
107
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$5.2M 0.09%
500,000
– –
OHPAU
108
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$4.96M 0.09%
500,000
– –
XENT
109
DELISTED
Intersect ENT, Inc
XENT
$4.37M 0.08%
255,456
– –
CABA icon
110
Cabaletta Bio
CABA
$439M
$3.99M 0.07%
464,252
– –
BMEA icon
111
Biomea Fusion
BMEA
$90.4M
$3.88M 0.07%
+248,447
New +$4.39M
BFLY.WS
112
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$3.54M 0.06%
733,333
– –
CMAXW
113
DELISTED
CareMax, Inc. Warrant
CMAXW
$3.17M 0.06%
672,000
– –
ACHL
114
DELISTED
Achilles Therapeutics
ACHL
$2.95M 0.05%
301,431
-498,569
-62% -$6.76M
CEREW
115
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$2.4M 0.04%
166,666
– –
TOIIW
116
The Oncology Institute Warrant
TOIIW
$2.16M 0.04%
1,250,000
– –
QSIAW
117
DELISTED
Quantum-Si Inc Warrant
QSIAW
$1.25M 0.02%
+333,333
New +$884K
MTCR
118
DELISTED
Metacrine, Inc. Common Stock
MTCR
$1.05M 0.02%
277,469
– –
NUVB.WS
119
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$433K 0.01%
166,666
– –
LUMO
120
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$331K 0.01%
33,117
-340,000
-91% -$3.78M
WINT
121
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
AUTL
122
Autolus Therapeutics
AUTL
$386M
– –
-2,142,857
Closed -$12.3M
BIIB icon
123
Biogen
BIIB
$29.9B
– –
-310,000
Closed -$86.7M
BOLT icon
124
Bolt Biotherapeutics
BOLT
$7.36M
– –
-17,500
Closed -$11.5M
BSX icon
125
Boston Scientific
BSX
$65.8B
– –
-2,857,000
Closed -$110M
2 3 4
5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2021 Portfolio in Review

As of Q2 2021, Deerfield Management held 166 positions worth $5.63B, up 18% from $4.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Deerfield Management withdrew a net $403M in Q2 2021, closing 23 positions and reducing 12 holdings. Its most notable exit was Boston Scientific, an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 71% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Deerfield Management opened a new position in Singular Genomics Systems, Inc. Common Stock worth $250M.

  • Deerfield Management's largest Q2 2021 buy was Singular Genomics Systems, Inc. Common Stock: 303,734 shares worth $250M.
  • Deerfield Management added most to AdaptHealth in Q2 2021, an estimated $145M increase.
  • Deerfield Management's biggest Q2 2021 reduction was Centene, cutting an estimated $67.9M.
  • Deerfield Management fully exited Boston Scientific in Q2 2021, selling an estimated $110M.
  • Deerfield Management's ten largest holdings make up 33% of its $5.63B portfolio in Q2 2021.
  • Deerfield Management opened 29 new positions and closed 23 in Q2 2021.
  • Deerfield Management's portfolio value rose 18% quarter-over-quarter to $5.63B.

Based on Deerfield Management's 13F filing for Q2 2021, filed 16 Aug 2021.